Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Rheumatoid Arthritis

  Free Subscription


18.05.2020

5 Ann Rheum Dis
6 Clin Rheumatol
1 Intern Med
1 PLoS One
1 Scand J Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. EMERY P, Burmester GR, Naredo E, Sinigaglia L, et al
    Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study.
    Ann Rheum Dis. 2020 May 13. pii: annrheumdis-2020-217246.
    PubMed         Abstract available

  2. SUN JL, Zhang HZ, Liu SY, Lian CF, et al
    Elevated EPSTI1 promote B cell hyperactivation through NF-kappaB signalling in patients with primary Sjogren's syndrome.
    Ann Rheum Dis. 2020;79:518-524.
    PubMed         Abstract available

  3. GODMANN L, Bollmann M, Korb-Pap A, Konig U, et al
    Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling.
    Ann Rheum Dis. 2020;79:481-489.
    PubMed         Abstract available

  4. KISSEL T, Reijm S, Slot LM, Cavallari M, et al
    Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications.
    Ann Rheum Dis. 2020;79:472-480.
    PubMed         Abstract available

  5. EMERY P, Horton S, Dumitru RB, Naraghi K, et al
    Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial.
    Ann Rheum Dis. 2020;79:464-471.
    PubMed         Abstract available


    Clin Rheumatol

  6. NG JY, Azizudin AM
    Rheumatoid arthritis and osteoarthritis clinical practice guidelines provide few complementary and alternative medicine therapy recommendations: a systematic review.
    Clin Rheumatol. 2020 May 8. pii: 10.1007/s10067-020-05054.
    PubMed         Abstract available

  7. BARBOSA-COBOS RE, Lugo-Zamudio G, Flores-Estrada J, Becerril-Mendoza LT, et al
    Correction to: Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.
    Clin Rheumatol. 2020 May 8. pii: 10.1007/s10067-020-05103.
    PubMed         Abstract available

  8. WANG BH, Lu YH, Wu LF, Lu X, et al
    Evaluation of plasma cytokine protein array profile: the highlighted PDGF-BB in rheumatoid arthritis.
    Clin Rheumatol. 2020 May 8. pii: 10.1007/s10067-020-05109.
    PubMed         Abstract available

  9. PEREZ-BARBOSA L, Garza-Elizondo MA, Vega-Morales D, Esquivel-Valerio JA, et al
    High frequency of rheumatic regional pain syndromes in first-degree relatives of patients with rheumatoid arthritis.
    Clin Rheumatol. 2020 May 9. pii: 10.1007/s10067-020-05029.
    PubMed         Abstract available

  10. GURLEVIK U, Karakoyun A, Yasar E
    When rheumatoid arthritis is mentioned, should only dryness come to mind?
    Clin Rheumatol. 2020 May 9. pii: 10.1007/s10067-020-05124.
    PubMed         Abstract available

  11. CAJIAO K, Gomez-Puerta JA
    Coexistence of antiphospholipid syndrome and cryoglobulinemia in a patient with rheumatoid arthritis.
    Clin Rheumatol. 2020 May 9. pii: 10.1007/s10067-020-05127.
    PubMed         Abstract available


    Intern Med

  12. KODA K, Toyoshima M, Nozue T, Suda T, et al
    Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.
    Intern Med. 2020 May 8. doi: 10.2169/internalmedicine.4275.
    PubMed         Abstract available


    PLoS One

  13. MOON J, Choi SH, Yoon CH, Kim MK, et al
    Gut dysbiosis is prevailing in Sjogren's syndrome and is related to dry eye severity.
    PLoS One. 2020;15:e0229029.
    PubMed         Abstract available


    Scand J Rheumatol

  14. MATSUOKA H, Kabata D, Taura A, Matsui T, et al
    Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis.
    Scand J Rheumatol. 2020;49:253-255.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: